Emerging Trends to Drive Gouty Arthritis Market Growth at 7.2% CAGR Through 2029

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Gouty Arthritis Market Size Growth Forecast: What to Expect by 2025?
The market size for gouty arthritis has seen robust growth in the past few years. The market is projected to expand from $3.44 billion in 2024 to $3.7 billion in 2025, recording a compound annual growth rate of 7.6%. The significant growth experienced in the historic period can be credited to factors such as a high incidence rate of chronic illnesses, increased consumption of alcohol, a surge in the aged population, wider acceptance of improved regeneration therapies, and a rise in healthcare spending.

How Will the Gouty Arthritis Market Size Evolve and Grow by 2029?
The market for gouty arthritis is projected to experience significant expansion in the upcoming years. The market is predicted to hit $4.9 billion by 2029, growing at a compound annual growth rate of 7.2%. This expected growth is due to developments in healthcare facilities, rising obesity rates, an increased occurrence of gout, and heightened public awareness. Key trends in the forecast period consist of an increased demand for efficient treatment procedures, regenerative therapies, technological progression, product introductions, and regulatory authorizations.

View the full report here:
https://www.thebusinessresearchcompany.com/report/gouty-arthritis-global-market-report

What Drivers Are Propelling the Growth of Gouty Arthritis Market Forward?
The escalating rates of obesity are anticipated to boost the expansion of the gouty arthritis market. Obesity is a health condition marked by the accumulation of excess body fat to a degree that poses a threat to a person's wellness and is typically evaluated utilizing the body mass index (BMI). The obesity prevalence is escalating owing to the heightened intake of calorie-rich, processed edibles and lethargic ways of living. Obesity escalates gouty arthritis by amplifying uric acid production and diminishing the body's capability to discharge it, resulting in the buildup of uric acid crystals in the joints. Also, surplus body mass puts more pressure on joints, escalating the inflammation and pain related to gout. For instance, in March 2022, the World Health Organization, a Switzerland-based specialized United Nations agency accountable for global public health, reported that roughly 1 billion persons, comprising 650 million adults, 340 million teenagers, and 39 million children were categorized as obese, with this number persistently rising. Also, forecasts suggest that about 167 million adults and children will face health repercussions due to overweight by 2025. Hence, the escalating occurrence of obesity is driving the expansion of the gouty arthritis market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16070&type=smp

Which Emerging Trends Are Transforming the Gouty Arthritis Market in 2025?
Key players in the gouty arthritis market are becoming more proactive in creating innovative products such as cortrophin gel. This increased drive is towards producing more potent and specific treatments for managing the disease. Cortrophin gel, which is also identified as repository corticotropin injection, is a refined version of the adrenocorticotropic hormone (ACTH). This hormone is utilized to handle multiple inflammatory and autoimmune conditions such as gouty arthritis. In a practical example, ANI Pharmaceuticals, a pharmaceutical company based in the US, gained clearance from the Food and Drug Administration in October 2023 for a 1-mL vial size of Purified Cortrophin Gel. This new product is designed for complementary treatment of certain patients who are suffering from acute gouty arthritis flares. Currently, Cortrophin Gel is the sole FDA-approved adrenocorticotropic hormone (ACTH) treatment for suitable patients experiencing acute gouty arthritis flares.

What Are the Key Segments in the Gouty Arthritis Market?
The gouty arthritis market covered in this report is segmented -

1) By Type: Acute Gouty Arthritis, Chronic Gouty Arthritis
2) By Treatment: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Pain Reliever, Corticosteroids, Xanthine Oxidase Inhibitors, Uricosurics, Others Treatments
3) By Diagnosis: Joint Fluid Test, Blood Test, X-Ray Imaging, Ultrasound, Dual Energy Computed Tomography (CT) Scan, Other Diagnosis
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Others Distribution Channels
5) By End-Users: Hospitals, Specialty Clinics, Other End-Users

Subsegments:
1) By Acute Gouty Arthritis: Monosodium Urate Crystals-Induced Acute Gout, Acute Gout Attack (Intermittent Flares), Severe Acute Gout With Joint Deformities
2) By Chronic Gouty Arthritis: Tophaceous Gout (Presence Of Uric Acid Deposits), Chronic Gout With Joint Damage, Chronic Gout With Renal Complications, Chronic Gout With Comorbidities (Hypertension, Diabetes)

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=16070&type=smp

Who Are the Key Players Shaping the Gouty Arthritis Market's Competitive Landscape?
Major companies operating in the gouty arthritis market are Pfizer Inc., Roche Holding AG, Merck & Co. Inc., AbbVie Inc., Bayer AG, Bristol Myers Squibb, AstraZeneca plc, Novartis International AG, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Gilead Sciences Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals Incorporated, UCB S.A., Boehringer Ingelheim International GmbH, Sun Pharmaceutical Industries Ltd., Horizon Therapeutics plc, Dr. Reddy's Laboratories Ltd., Amneal Pharmaceuticals Inc., Lupin Pharmaceuticals Inc.

What Geographic Markets Are Powering Growth in the Gouty Arthritis Market?
North America was the largest region in the gouty arthritis market in 2023. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the gouty arthritis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16070

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.